
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
Male, Blood Donors, Infectious and parasitic diseases, RC109-216, Keywords: HTLV-1 infections, human T-cell lymphotropic virus type 1, Prevalence, Humans, Mass Screening, viruses, Israel, Geography, R, Dispatch, emigration and immigration, Emigration and Immigration, HTLV-I Infections, HTLV-I Antibodies, HTLV-II Antibodies, Medicine, epidemiology, Female, Algorithms
Male, Blood Donors, Infectious and parasitic diseases, RC109-216, Keywords: HTLV-1 infections, human T-cell lymphotropic virus type 1, Prevalence, Humans, Mass Screening, viruses, Israel, Geography, R, Dispatch, emigration and immigration, Emigration and Immigration, HTLV-I Infections, HTLV-I Antibodies, HTLV-II Antibodies, Medicine, epidemiology, Female, Algorithms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
